Valuation of Your Early Drug Candidate
Preparing Your Company for the M&A Process
Best Practices for Fundraising and M&A Due Diligence
This whitepaper explores the importance of establishing early goals and objectives for the process, how to get the right people to ask the right questions in advance of the process, how to build credibility by defining goals and demonstrating they can be achieved, and much more.
Must-Know Finance Concepts for Life Sciences Valuations - Part II
This whitepaper discusses which asset valuation methodology is most used by big pharma to evaluate possible partners or acquisitions and an explanation of three fundamental concepts in valuation: risk-adjusted value, cost of capital, and present value.
Demystifying Tech M&A Valuation
This whitepaper shares the most common scenarios that arise when you are selling your company, the choices you have when negotiating the terms of the sale, and which choices are your best ones, as supported by academic research are covered.
Must-Know Finance Concepts for Life Sciences Valuations
Earnouts: Structures for Breaking Negotiation Deadlocks
This white paper features Senior M&A Executive Javier Enrile of Principal Global Investors. Mr. Enrile provides his extensive expertise to explain how earnout, (also "earn-out") structures work and how it can reduce risk for the buyer, add attractive incentives for the seller, and serve to break negotiation deadlocks and get deals consummated.
The $800 Billion Global Packaging Industry: Trends in M&A in 2018
M&A Integration‚ Maximizing the Return on Technology and Talent
Maximizing M&A Value, Minimizing Surprises
Best Practices for Responding to Inbound M&A Solicitations
This white paper focuses on the various types of buyers and their motivations, how to determine if entertaining an offer is the right decision for your business, how to determine the seller’s goals and roles post sale, what not to do when responding to offers, and how to match your desired outcome with the appropriate type of buyer.